aTYR PHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
aTYR PHARMA INC (ATYR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.27 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 300.00K shares, a 10.77% decline year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 3.97M shares, a 20.46% increase year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 156.40K shares, a 52.14% increase year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 79.40K shares, a 64.33% decline year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.87M shares, a 73.67% increase from fiscal 2024.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.23M shares, a 100.28% increase from fiscal 2023.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.11M shares, a 30.04% decline from fiscal 2022.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.59M shares, a 78.30% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 300.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 4.27M shares 10-Q · filed 2026-08-07 | 4.43M shares derived: sum of 3 quarters · filed 2026-08-07 | 4.51M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 3.97M shares 10-Q · filed 2026-05-15 | 4.13M shares derived: sum of 2 quarters · filed 2026-05-15 | 4.21M shares derived: sum of 3 quarters · filed 2026-05-15 | 4.55M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 156.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 235.80K shares derived: sum of 2 quarters · filed 2026-03-05 | 572.00K shares derived: sum of 3 quarters · filed 2026-03-05 | 3.87M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 79.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 415.60K shares derived: sum of 2 quarters · filed 2025-11-06 | 3.71M shares 10-Q · filed 2025-11-06 | 3.82M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 336.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 3.64M shares 10-Q · filed 2025-08-07 | 3.74M shares derived: sum of 3 quarters · filed 2025-08-07 | 3.96M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 3.30M shares 10-Q · filed 2025-05-07 | 3.40M shares derived: sum of 2 quarters · filed 2025-05-07 | 3.62M shares derived: sum of 3 quarters · filed 2025-05-07 | 3.78M shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 102.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 325.40K shares derived: sum of 2 quarters · filed 2025-03-13 | 478.80K shares derived: sum of 3 quarters · filed 2025-03-13 | 2.23M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 222.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 376.00K shares derived: sum of 2 quarters · filed 2024-11-07 | 2.13M shares 10-Q · filed 2024-11-07 | 2.13M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 153.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.90M shares 10-Q · filed 2024-08-13 | 1.90M shares derived: sum of 3 quarters · filed 2024-08-13 | 1.91M shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 1.75M shares 10-Q · filed 2024-05-02 | 1.75M shares derived: sum of 2 quarters · filed 2024-05-02 | 1.75M shares derived: sum of 3 quarters · filed 2024-05-02 | 1.92M shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 2.80K shares derived: sum of 2 quarters · filed 2024-03-14 | 174.40K shares derived: sum of 3 quarters · filed 2024-03-14 | 1.11M shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 2.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 174.40K shares derived: sum of 2 quarters · filed 2023-11-09 | 1.11M shares 10-Q · filed 2023-11-09 | 1.13M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 171.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.11M shares 10-Q · filed 2023-08-09 | 1.13M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.17M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 938.49K shares 10-Q · filed 2023-05-09 | 955.49K shares derived: sum of 2 quarters · filed 2023-05-09 | 1.00M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.20M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 17.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 62.40K shares derived: sum of 2 quarters · filed 2023-03-14 | 1.26M shares derived: sum of 3 quarters · filed 2023-03-14 | 1.59M shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 45.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 1.24M shares derived: sum of 2 quarters · filed 2022-11-14 | 1.57M shares 10-Q · filed 2022-11-14 | 1.72M shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 1.20M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.53M shares 10-Q · filed 2022-08-15 | 1.67M shares derived: sum of 3 quarters · filed 2022-08-15 | 1.67M shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 331.91K shares 10-Q · filed 2022-05-10 | 474.61K shares derived: sum of 2 quarters · filed 2022-05-10 | 478.41K shares derived: sum of 3 quarters · filed 2022-05-10 | 897.70K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 142.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 146.50K shares derived: sum of 2 quarters · filed 2022-03-15 | 565.78K shares derived: sum of 3 quarters · filed 2022-03-15 | 892.24K shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 3.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 423.08K shares derived: sum of 2 quarters · filed 2021-11-12 | 749.54K shares 10-Q · filed 2021-11-12 | 751.94K shares derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 419.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 745.74K shares 10-Q · filed 2021-08-11 | 748.14K shares derived: sum of 3 quarters · filed 2021-08-11 | 749.34K shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | 326.46K shares 10-Q · filed 2021-05-14 | 328.86K shares derived: sum of 2 quarters · filed 2021-05-14 | 330.06K shares derived: sum of 3 quarters · filed 2021-05-14 | 576.45K shares derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-12-31 | 2.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 3.60K shares derived: sum of 2 quarters · filed 2021-03-24 | 250.00K shares derived: sum of 3 quarters · filed 2021-03-24 | 412.43K shares 10-K · filed 2021-03-24 |
| 2020-09-30 | 1.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 247.60K shares derived: sum of 2 quarters · filed 2020-11-13 | 410.03K shares 10-Q · filed 2020-11-13 | 410.28K shares derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-06-30 | 246.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 408.83K shares 10-Q · filed 2020-08-13 | 409.08K shares derived: sum of 3 quarters · filed 2020-08-13 | 409.70K shares derived: sum of 4 quarters · filed 2020-08-13 |
| 2020-03-31 | 162.43K shares 10-Q · filed 2020-05-12 | 162.68K shares derived: sum of 2 quarters · filed 2020-05-12 | 163.30K shares derived: sum of 3 quarters · filed 2020-05-12 | -617.34K shares derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-12-31 | 250.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 870.00 shares derived: sum of 2 quarters · filed 2020-03-26 | -779.77K shares derived: sum of 3 quarters · filed 2020-03-26 | 76.72K shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 620.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -780.02K shares derived: sum of 2 quarters · filed 2019-11-14 | 76.47K shares 10-Q · filed 2019-11-14 | 138.77K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | -780.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 75.85K shares 10-Q · filed 2019-08-14 | 138.15K shares derived: sum of 3 quarters · filed 2019-08-14 | 364.15K shares derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | 856.49K shares 10-Q · filed 2019-05-14 | 918.79K shares derived: sum of 2 quarters · filed 2019-05-14 | 1.14M shares derived: sum of 3 quarters · filed 2019-05-14 | 1.70M shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 62.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 288.30K shares derived: sum of 2 quarters · filed 2019-03-26 | 840.60K shares derived: sum of 3 quarters · filed 2019-03-26 | 2.09M shares 10-K · filed 2019-03-26 |
| 2018-09-30 | 226.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 778.30K shares derived: sum of 2 quarters · filed 2018-11-14 | 2.03M shares 10-Q · filed 2018-11-14 | 2.50M shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 552.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 1.80M shares 10-Q · filed 2018-08-14 | 2.27M shares derived: sum of 3 quarters · filed 2018-08-14 | 2.28M shares derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | 1.25M shares 10-Q · filed 2018-05-15 | 1.72M shares derived: sum of 2 quarters · filed 2018-05-15 | 1.73M shares derived: sum of 3 quarters · filed 2018-05-15 | 1.99M shares derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | 466.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | 476.70K shares derived: sum of 2 quarters · filed 2018-03-20 | 742.40K shares derived: sum of 3 quarters · filed 2018-03-20 | 1.51M shares 10-K · filed 2018-03-20 |
| 2017-09-30 | 10.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 275.90K shares derived: sum of 2 quarters · filed 2017-11-14 | 1.04M shares 10-Q · filed 2017-11-14 | 1.05M shares derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | 265.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 1.03M shares 10-Q · filed 2017-08-14 | 1.03M shares derived: sum of 3 quarters · filed 2017-08-14 | 1.61M shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 765.72K shares 10-Q · filed 2017-05-11 | 769.22K shares derived: sum of 2 quarters · filed 2017-05-11 | 1.34M shares derived: sum of 3 quarters · filed 2017-05-11 | 1.72M shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 3.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 574.80K shares derived: sum of 2 quarters · filed 2017-03-16 | 955.85K shares derived: sum of 3 quarters · filed 2017-03-16 | 2.27M shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 571.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 952.35K shares derived: sum of 2 quarters · filed 2016-11-14 | 2.26M shares 10-Q · filed 2016-11-14 | 2.84M shares derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | 381.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | 1.69M shares 10-Q · filed 2016-08-10 | 2.27M shares derived: sum of 3 quarters · filed 2016-08-10 | 2.36M shares derived: sum of 4 quarters · filed 2016-08-10 |
| 2016-03-31 | 1.31M shares 10-Q · filed 2016-05-11 | 1.88M shares derived: sum of 2 quarters · filed 2016-05-11 | 1.98M shares derived: sum of 3 quarters · filed 2016-05-11 | |
| 2015-12-31 | 573.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 664.98K shares derived: sum of 2 quarters · filed 2016-03-30 | 1.72M shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 91.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 1.14M shares 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | 1.05M shares 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |